Latest updates
and insights.

Luzarraga Aznar A, Canton R, Loren G, Carvajal J, de la Calle I, Masferrer-Ferragutcasas C, Serra F, Bebia V, Bonaldo G, Angeles MA, Cabrera S, Palomar N, Vilarmau C, Martí M, Rigau M, Colas E, Gil-Moreno A. Current challenges and emerging tools in endometrial cancer diagnosis. Int J Gynecol Cancer. 2025;35(4):100056. doi:10.1016/j.ijgc.2024.100056.

Martinez-Garcia E, Lopez-Gil C, Campoy I, Vallve J, Coll E, Cabrera S, et al. Advances in endometrial cancer protein biomarkers for use in the clinic. Expert Rev Proteomics. 2018;15(1):81-99.

Martínez García E. protein signatures in uterine aspirates to improve diagnosis of endometrial cancer “The CEMARK project” [dissertation]. Barcelona: Universitat Autònoma de Barcelona, Departament de Biologia Cel·lular, de Fisiologia i d’Immunologia; 2017.

Martinez-Garcia E, Lesur A, Devis L, Cabrera S, Matias-Guiu X, Hirschfeld M, et al. Targeted proteomics identifies proteomic signatures in liquid biopsies of the endometrium to diagnose endometrial cancer and assist in the prediction of the optimal surgical treatment. Clin Cancer Res. 2017;23(21):6458-67. doi:10.1158/1078-0432.CCR-17-0474

Campoy I. Exosomes in uterine aspirates: characterization and identification of diagnostic and prognostic biomarkers in endometrial cancer [dissertation]. Barcelona: Universitat Autònoma de Barcelona; 2017.

Martinez-Garcia E, Lesur A, Devis L, Campos A, Cabrera S, van Oostrum J, et al. Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples. Oncotarget. 2016;7(33):53102-15.